Powder: -20°C for 3 years | In solvent: -80°C for 1 year
YH-306 (TRV055 acetate ) is a modulator of the FAK signaling pathway that acts by suppressing colorectal tumor growth and metastasis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 47.00 | |
10 mg | In stock | $ 80.00 | |
25 mg | In stock | $ 163.00 | |
50 mg | In stock | $ 247.00 | |
100 mg | In stock | $ 372.00 | |
200 mg | In stock | $ 549.00 | |
500 mg | In stock | $ 869.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 68.00 |
Description | YH-306 (TRV055 acetate ) is a modulator of the FAK signaling pathway that acts by suppressing colorectal tumor growth and metastasis. |
In vitro | YH-306 suppresses the activation of FAK, c-Src, paxillin, and PI3K, Rac1, and the expression of MMP2 and MMP9. YH-306 potently suppresses uninhibited proliferation and induces cell apoptosis. YH-306 inhibits Arp2/3 complex-mediated actin polymerization[1]. |
Synonyms | YH306, TRV055 acetate (25849-90-5 Free base) |
Molecular Weight | 306.36 |
Formula | C19H18N2O2 |
CAS No. | 1373764-75-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 15 mg/mL (48.96 mM), when pH is adjusted to 1 with HCl. Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
YH-306 1373764-75-0 Angiogenesis Cell Cycle/Checkpoint Cytoskeletal Signaling PI3K/Akt/mTOR signaling Proteases/Proteasome Tyrosine Kinase/Adaptors MMP FAK Rho PI3K Src 25849-90-5 YH 306 YH306 TRV 055 Acetate TRV055 acetate (25849-90-5 Free base) TRV055 Acetate 25849-90-5 Free base TRV-055 Acetate inhibitor inhibit